Numbers Consolidated Financial Statement Separate Financial Statement Q2/2017 Q2/2016 %variance Q2/2017 Q2/2016 %variance 1. Main income (million THB) 2,038.31 5,162.83 (60.52%) 1,665.18 4,661.26 (64.28%) 2
: Profit/Loss Statement in Q3/2017 and 2016 Numbers Consolidated Financial Statement Separate Financial Statement Q3/2017 Q3/2016 %variance Q3/2017 Q3/2016 %variance 1. Main income (million THB) 2,346.48
2017 and 2016 Table 1: Profit/Loss Statement in 2017 and 2016 Numbers Consolidated Financial Statement Separate Financial Statement 2017 2016 %variance 2017 2016 %variance 1. Main income (million THB
ratio of the Company and subsidiary companies Unit: Million THB Type of Income Q2/2019 Q2/2018 %variance First Half 2019 First Half 2018 % variance Note 1. Income from Sale of Real Estate 1 1,366.28
performance as of April 21, 2020 of the company and its subsidiaries was changed accordingly. Table: Operating Results (Unit: Million Baht) Items Quarter Variance 1/2020 1/2019 Amount (%YoY) Interest income
. Operating performance summary for the period ended September 30, 2017 Unit: million baht July-September January-September 2017 2016 Variance 2017 2016 Variance Amount % Amount % Net profit (loss) for the
increase in Revenues from hospital operations. Administrative expenses (including Depreciation and amortization) were Baht 128.42 million in 2018 or 28.57% more than Baht 99.88 million in 2017. The variance
amortization) were Thai Baht 195.04 million in 2019 or 51.88% more than Thai Baht 128.42 million in 2018. The variance was mostly due to an increase in employee expenses and sales promotion expenses. EBITDA
-year from Baht 27.64 million in 1Q18. The variance was mostly due to an increase in number of patients, depreciation and employee management expenses. EBITDA increased by 112.55% year- over-year to Baht
variance was mostly due to an increase in employee expenses. Profit to equity holders of the company in 1Q20 decreased by 74.83% year‐over‐year to THB 11.25 million from THB 44.70 million in